Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 8465
TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250510(US9469639, Compound (IV))
Affinity DataIC50: 4.30nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250511(US9469639, Compound (III))
Affinity DataIC50: 5.10nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250510(US9469639, Compound (IV))
Affinity DataIC50: 6.70nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM16673(Xarelto | BAY439006 | CHEMBL1336 | BAY 43-9006 | 4...)
Affinity DataIC50: 11.1nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250509(US9469639, Compound (V))
Affinity DataIC50: 16.3nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM16673(Xarelto | BAY439006 | CHEMBL1336 | BAY 43-9006 | 4...)
Affinity DataIC50: 18.4nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250514(US9469639, Compound (VIII))
Affinity DataIC50: 21nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250511(US9469639, Compound (III))
Affinity DataIC50: 25.4nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250509(US9469639, Compound (V))
Affinity DataIC50: 30.4nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250512(US9469639, Compound (VI))
Affinity DataIC50: 45.4nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250512(US9469639, Compound (VI))
Affinity DataIC50: 47.8nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250513(US9469639, Compound (VII))
Affinity DataIC50: 48.3nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250513(US9469639, Compound (VII))
Affinity DataIC50: 106nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Radiant Pharma & Tech.

US Patent
LigandPNGBDBM250514(US9469639, Compound (VIII))
Affinity DataIC50: 155nMT: 2°CAssay Description:Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 g/ml with potassium ion-free PBS, and enzyme labeled plate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/18/2017
Entry Details
US Patent